Abiopharma

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Lexaria Bioscience Corp. - Warrant.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Co-Diagnostics, Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Co-Diagnostics, Inc. - Common Stock. New value: Co-Diagnostics, Inc. - Common Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Lexaria Bioscience Corp. - Warrant.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Co-Diagnostics, Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Denium Therapeutics, Inc - Common Shares. New value: Mind Medicine (MindMed) Inc. - Common Shares.

NASDAQ symbol attribute type Security_Name was changed. Previous value: BriaCell Therapeutics Corp. - Warrant. New value: BriaCell Therapeutics Corp. - Warrant expiring 2026.

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm

Обновление данных компании I.S.A HOLDINGS LTD (8 изменений)

Integer Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ITGR

agilon health, inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - AGL

[Press Release] HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet

New Form S-1MEF - PLUS THERAPEUTICS, INC. Filed: 2026-01-13 AccNo: 0001193125-26-012091 Size: 317 KB

HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.